www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

C3b/iC3b, Human, mAb 5G9

Catalogue number:
HM2285-500UG
Supplier:
Size:
500 µg _$$_
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£1232.00 Shipping is calculated in checkout
Applications:

Functional studies

Product Description:

The monoclonal antibody 5G9 recognizes Complement Factor C3b/iC3b, it specifically binds human C3 as well as the breakdown products C3b and iC3b. C3 plays a central role in the activation of the complement system. Its activation is required for both classical and alternative complement activation pathways. People with C3 deficiency are susceptible to bacterial infection.One form of C3-convertase, also known as C4b2a, is formed by a heterodimer of activated forms of C4 and C2. It catalyzes the proteolytic cleavage of C3 into C3a and C3b, generated during activation through the classical pathway as well as the lectin pathway. C3a is an anaphylotoxin and the precursor of some cytokines such as ASP, and C3b serves as an opsonizing agent. Factor I can cleave C3b into C3c and C3d, the latter of which plays a role in enhancing B cell responses. In the alternative complement pathway, C3 is cleaved by C3bBb, another form of C3-convertase composed of activated forms of C3 (C3b) and factor B (Bb). Once C3 is activated to C3b, it exposes a reactive thioester that allows the peptide to covalently attach to any surface that can provide a nucleophile such as a primary amine or a hydroxyl group. Activated C3 can then interact with factor B. Factor B is then activated by factor D, to form Bb. The resultant complex, C3bBb, is called the alternative pathway (AP) C3 convertase.C3bBb is deactivated in steps. First, the proteolytic component of the convertase, Bb, is removed by complement regulatory proteins having decay-accelerating factor (DAF) activity. Next, C3b is broken down progressively to first iC3b, then C3c + C3dg, and then finally C3d. Factor I is the protease that performs these cuts with CR1 as cofactor. Clone 5G9 recognize separate, non-overlapping epitopes on C3 fragments. Levels of C3 in the blood may be measured to support or refute a particular medical diagnosis. For example, low C3 levels are associated with some types of kidney disease such as post-infectious glomerulonephritis and shunt nephritis.

HM2285-500UG C3b/iC3b, Human, mAb 5G9
HM2285-500UG C3b/iC3b, Human, mAb 5G9
Details Cat number & supplier Size Price
C3b/iC3b, Human, mAb 3E7 HM2286-500UG · Hycult Biotech
HM2286-500UG
Hycult Biotech
500 µg £1232.00
500 µg
view
CD73, Human, mAb 4G4 HM2215-500UG · Hycult Biotech
HM2215-500UG
Hycult Biotech
500 µg £1232.00
500 µg
view
Lipopolysaccharide Core, mAb WN1 222-5 HM6011-500UG · Hycult Biotech
HM6011-500UG
Hycult Biotech
500 µg £1232.00
500 µg
view
MARCO, Human, mAb PLK-1 HM2208-500UG · Hycult Biotech
HM2208-500UG
Hycult Biotech
500 µg £1232.00
500 µg
view
C3a, Mouse, mAb 3/11 HM1072-500UG · Hycult Biotech
HM1072-500UG
Hycult Biotech
500 µg £1232.00
500 µg
view
Galectin-3, Human, mAb B2C10 HM2186-500UG · Hycult Biotech
HM2186-500UG
Hycult Biotech
500 µg £1232.00
500 µg
view
RBC, Mouse, mAb 34-3C HM1120-500UG · Hycult Biotech
HM1120-500UG
Hycult Biotech
500 µg £1232.00
500 µg
view
TCC, Human, mAb aE11 HM2167-500UG · Hycult Biotech
HM2167-500UG
Hycult Biotech
500 µg £1232.00
500 µg
view
CD166, Human, mAb AZN-L50 HM2002-500UG · Hycult Biotech
HM2002-500UG
Hycult Biotech
500 µg £1232.00
500 µg
view
CD46, Human, mAb M177 HM2103-500UG · Hycult Biotech
HM2103-500UG
Hycult Biotech
500 µg £1232.00
500 µg
view